CMSC: Natalizumab for MS During the Covid-19 Pandemic
Overall outcomes good after Covid infection, vaccine for most patients At the recent Consortium of...
Read More
CMSC 2021
CMSC: Real-World Study Confirms Dimethyl Fumarate Safety
GI disorders most common reason for Tx discontinuation Safety is always a concern for any...
Read More
CMSC: Most MS Providers Think Diroximel Fumarate Has Better GI Profile
Prescribers cite tolerability when switching from other DMTs For those who doubt the effectiveness...
Read MoreCOVID-19 Pandemic Profoundly Changes Delivery of MS Care
The COVID-19 pandemic resulted in unforeseen changes in healthcare delivery for patients with MS, and the pandemic’s swift progression led to a knowledge gap about how the virus has impacted practice patterns for MS clinicians,...
Read MoreCOVID-19 Pandemic Negatively Impacts Social Well-Being of Patients With MS
Currently, no research has reviewed the social consequences of the COVID-19 pandemic on patients with MS, who may experience greater social strain and more serious health consequences because of isolation measures, according to...
Read More
CMSC: Aggressive Versus Escalating MS Treatment Strategies
Ongoing trials may shed light on which is better In people newly diagnosed with relapsing multiple...
Read MoreCMSC 2021 Annual Meeting Around the Corner
This year’s Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting, the leading research and educational conference for MS healthcare professionals in North America, kicks off tomorrow, October 25 through October...
Read MoreTelerehabilitation During Isolation Improves QOL in Patients With MS
Investigators sought to assess the impact of telerehabilitation in patients with MS during the isolation period of the COVID-19 pandemic. They conducted a retrospective analysis using medical records from adults with MS and...
Read MoreWellness Program Improves QOL in MS
Data presented at prior CMSC meetings described baseline, 1-year, and 2-year results of the Multiple Sclerosis Achievement Center, which assessed day wellness programs targeting physical, cognitive, and social well-being in...
Read MoreCMSC 2021: Social Support, Not Fatigue Affects Physical Activity in Patients With MS
The lack of behavioral interventions that aim to increase physical activity (PA) among individuals with fatigue prompted researchers to examine variables of social cognitive theory (SCT) as correlates of PA among adult patients...
Read MoreMediators of Racial Disparities in MS Identified
Research demonstrates that Black Americans with MS experience more aggressive disease and a higher lesion burden when compared with White Americans, but the factors associated with these disparities have not been examined. To...
Read More